chr9-70282476-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015110.4(SMC5):āc.874G>Cā(p.Val292Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000498 in 1,607,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015110.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMC5 | NM_015110.4 | c.874G>C | p.Val292Leu | missense_variant | 7/25 | ENST00000361138.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMC5 | ENST00000361138.7 | c.874G>C | p.Val292Leu | missense_variant | 7/25 | 1 | NM_015110.4 | P1 | |
SMC5 | ENST00000618375.1 | n.5G>C | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245204Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132526
GnomAD4 exome AF: 0.0000536 AC: 78AN: 1455348Hom.: 0 Cov.: 29 AF XY: 0.0000387 AC XY: 28AN XY: 723586
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.874G>C (p.V292L) alteration is located in exon 7 (coding exon 7) of the SMC5 gene. This alteration results from a G to C substitution at nucleotide position 874, causing the valine (V) at amino acid position 292 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at